Curcumin monomer regulates ferroptosis via the melatonin receptor 2/cyclic adenosine monophosphate/protein kinase A/inositol-requiring enzyme 1 pathway to treat ischemic stroke.

Researchers investigated whether curcumin, a natural compound found in turmeric, could protect the brain from damage caused by ischemic stroke. Ischemic stroke occurs when blood flow to the brain is blocked, leading to cell death and neurological problems. Scientists used rats with induced strokes and tested different doses of curcumin (50, 100, or 200 mg/kg) given before the stroke occurred. They also studied brain cells in the laboratory under oxygen-deprived conditions that mimic stroke. The results showed that curcumin pre-treatment significantly improved neurological function, reduced brain swelling, protected the blood-brain barrier, and decreased cell death. The compound worked by activating a specific molecular pathway involving melatonin receptors and other proteins that help protect brain cells from a type of cell death called ferroptosis, which involves iron accumulation and oxidative stress. Curcumin also reduced inflammation and improved cell survival rates. While this research is promising for understanding how natural compounds might protect the brain, it's important to note that this was an animal and laboratory study, not a human clinical trial. For patients interested in integrative approaches to stroke recovery or prevention, acupuncture has shown benefits in multiple studies for post-stroke rehabilitation, helping with motor function, speech, and overall recovery. If you're considering acupuncture as part of your stroke recovery or general wellness plan, seek care from a licensed acupuncturist with experience in neurological conditions.

This preclinical study investigated curcumin's neuroprotective mechanisms in ischemic stroke using middle cerebral artery occlusion (MCAO) rat models and oxygen-glucose deprivation/reperfusion (OGD/R) HT-22 cell models. Curcumin pre-treatment at doses of 50, 100, and 200 mg/kg significantly improved neurological deficit scores, reduced cerebral edema, and preserved blood-brain barrier integrity. The study demonstrated that curcumin's neuroprotection operates through activation of the MT2/cAMP/PKA/IRE1 signaling pathway, specifically targeting ferroptosis—an iron-dependent form of regulated cell death. In vitro results showed enhanced cell viability, reduced apoptosis, and decreased markers of ferroptosis, oxidative stress, and inflammation. Neuronal morphology was preserved, and iron accumulation in brain tissue was reduced. These findings suggest curcumin modulates multiple pathological mechanisms in ischemic injury through melatonin receptor-mediated pathways. While promising for understanding phytochemical neuroprotection, clinical translation requires human trials. Practitioners may consider discussing curcumin supplementation as adjunctive support, though evidence for post-stroke efficacy in humans remains limited compared to established acupuncture protocols for stroke rehabilitation.